newsfilter
← Latest News
PR Newswire·

MEDIVIR AB - INTERIM REPORT JANUARY - SEPTEMBER 2022

STOCKHOLM, Nov. 3, 2022 /PRNewswire/ -- The measures to increase the pace of patient recruitment have yielded results. The Fostrox study is now progressing as expected. July – SeptemberFinancial summary for the